BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29363940)

  • 1. N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action.
    Schlott AC; Holder AA; Tate EW
    ACS Infect Dis; 2018 Apr; 4(4):449-457. PubMed ID: 29363940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of protein N-myristoylation blocks Plasmodium falciparum intraerythrocytic development, egress and invasion.
    Schlott AC; Knuepfer E; Green JL; Hobson P; Borg AJ; Morales-Sanfrutos J; Perrin AJ; Maclachlan C; Collinson LM; Snijders AP; Tate EW; Holder AA
    PLoS Biol; 2021 Oct; 19(10):e3001408. PubMed ID: 34695132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of myristoylation in
    Broncel M; Dominicus C; Vigetti L; Nofal SD; Bartlett EJ; Touquet B; Hunt A; Wallbank BA; Federico S; Matthews S; Young JC; Tate EW; Tardieux I; Treeck M
    Elife; 2020 Jul; 9():. PubMed ID: 32618271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors.
    Schlott AC; Mayclin S; Reers AR; Coburn-Flynn O; Bell AS; Green J; Knuepfer E; Charter D; Bonnert R; Campo B; Burrows J; Lyons-Abbott S; Staker BL; Chung CW; Myler PJ; Fidock DA; Tate EW; Holder AA
    Cell Chem Biol; 2019 Jul; 26(7):991-1000.e7. PubMed ID: 31080074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from Plasmodium falciparum: an insight into novel antimalarial drug design.
    Paul P; Chowdhury A; Das Talukdar A; Choudhury MD
    J Mol Model; 2015 Mar; 21(3):37. PubMed ID: 25663521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in probing and targeting protein acylation in malaria, leishmaniasis and African sleeping sickness.
    Ritzefeld M; Wright MH; Tate EW
    Parasitology; 2018 Feb; 145(2):157-174. PubMed ID: 28270257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Selective Inhibitors of
    Harupa A; De Las Heras L; Colmenarejo G; Lyons-Abbott S; Reers A; Caballero Hernandez I; Chung CW; Charter D; Myler PJ; Fernández-Menéndez RM; Calderón F; Palomo S; Rodríguez B; Berlanga M; Herreros-Avilés E; Staker BL; Fernández Álvaro E; Kaushansky A
    J Med Chem; 2020 Jan; 63(2):591-600. PubMed ID: 31850752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global analysis of protein N-myristoylation and exploration of N-myristoyltransferase as a drug target in the neglected human pathogen Leishmania donovani.
    Wright MH; Paape D; Storck EM; Serwa RA; Smith DF; Tate EW
    Chem Biol; 2015 Mar; 22(3):342-54. PubMed ID: 25728269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of protein N-myristoylation: a therapeutic protocol in developing anticancer agents.
    Das U; Kumar S; Dimmock JR; Sharma RK
    Curr Cancer Drug Targets; 2012 Jul; 12(6):667-92. PubMed ID: 22463587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach.
    Wright MH; Clough B; Rackham MD; Rangachari K; Brannigan JA; Grainger M; Moss DK; Bottrill AR; Heal WP; Broncel M; Serwa RA; Brady D; Mann DJ; Leatherbarrow RJ; Tewari R; Wilkinson AJ; Holder AA; Tate EW
    Nat Chem; 2014 Feb; 6(2):112-21. PubMed ID: 24451586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.
    Yu Z; Brannigan JA; Moss DK; Brzozowski AM; Wilkinson AJ; Holder AA; Tate EW; Leatherbarrow RJ
    J Med Chem; 2012 Oct; 55(20):8879-90. PubMed ID: 23035716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.
    Lodge JK; Jackson-Machelski E; Devadas B; Zupec ME; Getman DP; Kishore N; Freeman SK; McWherter CA; Sikorski JA; Gordon JI
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():357-366. PubMed ID: 9043113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.
    Duronio RJ; Jackson-Machelski E; Heuckeroth RO; Olins PO; Devine CS; Yonemoto W; Slice LW; Taylor SS; Gordon JI
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1506-10. PubMed ID: 2406721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis.
    Tate EW; Bell AS; Rackham MD; Wright MH
    Parasitology; 2014 Jan; 141(1):37-49. PubMed ID: 23611109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the discovery of N-myristoyltransferase inhibitors.
    Zhao C; Ma S
    ChemMedChem; 2014 Nov; 9(11):2425-37. PubMed ID: 25125080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
    Bell AS; Mills JE; Williams GP; Brannigan JA; Wilkinson AJ; Parkinson T; Leatherbarrow RJ; Tate EW; Holder AA; Smith DF
    PLoS Negl Trop Dis; 2012; 6(4):e1625. PubMed ID: 22545171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of 2-substituted derivatives of myristic acid to form potent inhibitors of myristoyl CoA:protein N-myristoyltransferase.
    Paige LA; Zheng GQ; DeFrees SA; Cassady JM; Geahlen RL
    Biochemistry; 1990 Nov; 29(46):10566-73. PubMed ID: 2271666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel inhibitor protein of N-myristoyltransferase from Escherichia coli.
    Gowda S; Shrivastav A; Selvakumar P; Dimmock JR; Sharma RK
    Biochem Biophys Res Commun; 2004 Feb; 314(4):984-7. PubMed ID: 14751229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds.
    Crowther GJ; Napuli AJ; Gilligan JH; Gagaring K; Borboa R; Francek C; Chen Z; Dagostino EF; Stockmyer JB; Wang Y; Rodenbough PP; Castaneda LJ; Leibly DJ; Bhandari J; Gelb MH; Brinker A; Engels IH; Taylor J; Chatterjee AK; Fantauzzi P; Glynne RJ; Van Voorhis WC; Kuhen KL
    Mol Biochem Parasitol; 2011 Jan; 175(1):21-9. PubMed ID: 20813141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-myristoylation: from cell biology to translational medicine.
    Yuan M; Song ZH; Ying MD; Zhu H; He QJ; Yang B; Cao J
    Acta Pharmacol Sin; 2020 Aug; 41(8):1005-1015. PubMed ID: 32203082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.